Since CD133+ melanoma cells are rare in clinical samples and difficult to isolate from surgical specimens, the expression of stem cell surface markers, in particular CD133, was analyzed in 9 well-established human melanoma cell lines, each and every one originally derived from human metastatic malignant melanoma. This evidence concerns the gene PROM1 and melanoma.